Tasimelteon Purification via Segmented Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of tasimelteon often results in the formation of impurities, both as by-products and degradation products, which can affect the purity and quality of the final pharmaceutical product.
Innovation Solution
A process is developed to synthesize highly purified, pharmaceutical-grade tasimelteon by propionylating ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl) methanamine, followed by crystallization and rigorous impurity analysis to ensure that the product meets pre-set specifications for impurities such as Impurity 5 and Impurity 6.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthesis methods are used to produce tasimelteon, then the production process is simpler and faster, but impurities are formed that reduce product purity and quality
Solution Approach 1:
The synthesis process is divided into multiple discrete steps with specific purification operations between them. Each step produces a specific intermediate that is purified before the next step, segmenting the overall process to control impurity formation at each stage rather than attempting to purify everything at the end.
Solution Approach 2:
Specific purification operations are extracted and inserted at critical points in the synthesis pathway. These extraction operations (such as filtration, crystallization, or chromatography) remove specific impurities that are formed during each step, allowing the main synthesis to proceed while continuously eliminating harmful by-products.
2Manufacturing precision
If additional purification steps are added to reduce impurities, then product purity improves, but production time and process complexity increase
Solution Approach 1:
Purification operations are performed preliminarily between synthesis steps rather than waiting for the final step. By removing impurities early in the process, subsequent steps can proceed more efficiently without requiring extensive final purification, thus reducing overall production time while maintaining high purity.
Solution Approach 2:
The process incorporates monitoring and analysis at key stages to determine when purification is actually needed. Feedback from quality testing allows the process to adjust - if impurity levels are already low, additional purification can be skipped, optimizing both purity and time efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process effectively controls and reduces impurities to non-detectable or acceptably detectable levels, ensuring the production of highly purified tasimelteon that meets pharmaceutical standards.
Implementation Method 1
crystallizing the tasimelteon produced in step (a)
Data Source
AI summary
A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.